Title Image

Latest News

The Science is In: Testosterone Therapy is Safe and Effective

If you’re a man experiencing symptoms like low libido, decreased energy, changes in mood, or loss of muscle mass, you might be suffering from hypogonadism, a condition caused by low testosterone levels. But fear not, there’s a solution: testosterone-replacement therapy (TRT). TRT has long been known to alleviate these symptoms and improve overall quality of life in men with hypogonadism. However, concerns about its safety, particularly its potential impact on cardiovascular health, have lingered in both medical circles and among patients.

At the Burick Center, led by Dr. Adam Burick and his team of experts, we believe in providing evidence-based care that prioritizes patient safety and well-being. Today, we’re thrilled to share the latest research that confirms what we’ve long believed: testosterone therapy is safe and effective for men with hypogonadism.

One of the most significant studies supporting the safety of TRT is the Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficiency Response in Hypogonadal Men (TRAVERSE) trial. This groundbreaking study, initiated by the Food and Drug Administration (FDA), aimed to address concerns surrounding the cardiovascular risks associated with TRT. The TRAVERSE trial involved over 5,200 men aged 45 to 80 who either had preexisting cardiovascular disease or were at high risk of developing it, all of whom had confirmed hypogonadism.

The results of the TRAVERSE trial were nothing short of reassuring. Contrary to some previous concerns, the study found that testosterone therapy did not increase the risk of major adverse cardiac events in men with hypogonadism. Over an average treatment duration of 22 months, the incidence of cardiovascular events was similar between the group receiving TRT and the placebo group. This finding dispels the notion that testosterone therapy poses significant cardiovascular risks.

However, it’s essential to address some important nuances highlighted by the study. While overall cardiovascular events did not differ significantly between the groups, there were slightly higher rates of specific adverse events, such as atrial fibrillation and acute kidney injury, in the TRT group. These findings underscore the importance of individualized treatment decisions and close monitoring by healthcare providers when initiating TRT, particularly in patients with preexisting cardiovascular conditions.

Dr. Steven Nissen, senior author of the TRAVERSE trial, emphasizes the need for caution and informed decision-making when considering testosterone therapy. While the study provides valuable insights into its safety profile, TRT should not be indiscriminately prescribed without careful consideration of each patient’s medical history and risk factors.

Moreover, it’s crucial to debunk common misconceptions surrounding testosterone therapy. Despite its proven benefits for men with hypogonadism, TRT should not be viewed as a panacea or pursued without medical supervision. Natural testosterone boosters and other non-prescription remedies lack rigorous clinical evaluation and may carry unknown risks. Men with low testosterone should seek guidance from qualified healthcare professionals like those at the Burick Center to ensure safe and effective treatment.

In conclusion, the science is unequivocal: testosterone therapy is a safe and effective option for men with hypogonadism. With careful consideration and guidance from experienced clinicians, men can reclaim their vitality and improve their quality of life with TRT. At the Burick Center, we’re committed to providing personalized care that prioritizes your health and well-being. Contact us today to learn more about how testosterone therapy can benefit you. 717-730-9000

[Reference: Cleveland Clinic-led TRAVERSE trial presented at ENDO 2023; New England Journal of Medicine publication]1

*The Burick Center serves Mechanicsburg, Harrisburg, York, Camp Hill, Carlisle, Enola, Lancaster and surrounding areas

Receive the latest news, events and health tips!

  • Hidden